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INTRODUCTION 
Angiogenesis is essential for tumor survival and 
progression in that it provides a blood supply for 
the tumor to increase in size, and TGF-β Smad-
dependent signaling is critical in regulating this 
process. Endoglin, a transmembrane coreceptor of 
the TGF-β pathway, is expressed in endothelial 
cells including those of the vasculature, and thus 
contributes to regulation of pro- and anti-
angiogenic processes. Recently, our lab discovered 
novel cross-talk between the insulin and TGF-β 
pathways. The purpose of this study is to examine 
the role of endoglin in insulin-mediated Smad 
signaling. Phosphorylated Smad1/5/8 is a pro-
angiogenic transcription factor that cancer tumors 
need to grow. Immunofluorescence and 
biochemical methods were used to see cellular 
changes and differences in protein concentrations. 
Preliminary data shows that insulin treated cells 
that contain endoglin have a higher concentration 
of phosphorylated Smad1/5/8. 
METHODS 
Western  blotting  was  used  to  determine  relative 
amounts  of  endoglin  under  various  conditions. 
Immunofluorescence was used to directly visualize 
endoglin and insulin in the cell and whether they 
are overlapping, indicating interaction between the 
two proteins. Immunoprecipitation was used to see 
whether  insulin  receptor  was  interacting  with 
endolgin  by  immunoprecipitating  endoglin  and 
blotting  for  insulin  receptor.  The  blot  reveals 
whether insulin receptor was attached to endoglin 
in vitro. 	  
CONCLUSIONS 
•  Insulin treated cells that contain endoglin have 
a higher concentration of phosphorylated 
Smad 1/5/8 compared to endoglin null cells. 
•  Given that type 2 diabetic patients are 
susceptible to a number of vascular-related 
conditions and malignancies, our results reveal 
new pathophysiologic implications for 
Smad1/5/8 signaling through hyperinsulinemia 
during pre-diabetic and diabetic disease 
progression.  
•  The findings of this study may provide 
information to better understand how type 2 
d i a b e t i c p a t i e n t s d e v e l o p v a s c u l a r 
abnormalities and cancer.  
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HYPOTHESIS 
The purpose of this study is to examine whether 
endoglin in insulin-mediated Smad signaling 
activates phosphorylation of Smad1/5/8, a 
proangiogenic transcription factor. 
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Fig 2. Western blot showing the induction of p-Smad  
1/5/8 in the presence of endoglin due to the insulin treatment,  
indicating that endoglin is required for insulin to stimulate 
Smad 1/5/8 activation. 
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Fig 1. Balance between Smad1/5/8 and Smad2/3 is critical in  
regulation of cellular processes. 
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Insulin Receptor and Endoglin Directly Interact 
Fig 4. Blot showing immunoprecipitatation of endoglin and  
insulin receptor from endothelial cells supports that insulin  
receptor is directly interacting with endoglin in vitro.  
Endoglin	  YE	  	   Insulin	  Receptor	  GFP	   Merged	  
Endoglin	  YE	  	   Insulin	  Receptor	  GFP	   Merged	  
Endoglin and Insulin Receptor Co-localize 
Fig. 3: Immunofluorescence labeling of endolgin (red) and 
insulin receptor (green) in endothelial cells demonstrates 
co-localization in vitro (yellow).  
	  
Fig 5: Western blotting reveals that ALK1 inhibition reduces 
in vitro activation of Smad 1/5/8 upon insulin stimulation in  
endoglin positive endothelial cells, indicating that endoglin and  
ALK1 are needed for insulin-induced Smad 1/5/8 activation. 
  
